US Capitol Capsule: Pharma plays multiple vital roles in US security strategy
This article was originally published in Scrip
From trade to improving global health, the biopharmaceutical industry is playing multiple vital roles in President Barack Obama's 2015 National Security Strategy, unveiled on 6 February.
You may also be interested in...
Ken Frazier says advocates need to ensure governments continue investing in global biosecurity.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.